Insider Transactions in Q1 2021 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2021
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,211
+0.15%
|
$11,055
$5.0 P/Share
|
|
Mar 24
2021
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,030
+0.07%
|
$5,150
$5.0 P/Share
|
|
Mar 24
2021
|
Arie Belldegrun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,241
+1.3%
|
$16,205
$5.0 P/Share
|
|
Jan 31
2021
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.02%
|
-
|
|
Jan 31
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,076
-4.93%
|
$23,672
$22.07 P/Share
|
|
Jan 31
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Jan 26
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-0.5%
|
$2,200
$22.12 P/Share
|
|
Jan 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+1.03%
|
-
|
|
Jan 03
2021
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,807
+3.57%
|
-
|